A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect
Author(s) -
Henk Rozemuller,
Ellen van der Spek,
Lijnie Bogers-Boer,
M. C. Zwart,
Viviènne Verweij,
Maarten E. Emmelot,
Richard W.J. Groen,
Robbert M. Spaapen,
A C Bloem,
H M Lokhorst,
Tuna Mutis,
Anton C. Martens
Publication year - 2008
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.12349
Subject(s) - multiple myeloma , medicine , bioluminescence imaging , bone marrow , cancer research , immunotherapy , peripheral blood mononuclear cell , in vivo , immunoglobulin light chain , pathology , luciferase , immune system , cell culture , immunology , in vitro , biology , antibody , transfection , biochemistry , microbiology and biotechnology , genetics
The development and preclinical testing of novel immunotherapy strategies for multiple myeloma can benefit substantially from a humanized animal model that enables quantitative real-time monitoring of tumor progression. Here we have explored the feasibility of establishing such a model in immunodeficient RAG2(-/-)gammac(-/-) mice, by utilizing non-invasive bioluminescent imaging for real-time monitoring of multiple myeloma cell growth.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom